QT
KZR

Quantbot Technologies’s Kezar Life Sciences KZR Stock Holding History

Quantbot Technologies’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-793
Closed -$9.44K – 1801
2023
Q3 		$9.44K Sell
793
-1,577
-67% -$27.9K ﹤0.01% 1415
2023
Q2 		$58.1K Buy
2,370
+2,260
+2,055% +$58.8K ﹤0.01% 1291
2023
Q1 		$3.44K Buy
+110
New +$6.37K ﹤0.01% 1456

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's KZR Position: Q4 2023 in Review

Quantbot Technologies sold out of Kezar Life Sciences (KZR) in Q4 2023, closing a stake of 793 shares — an estimated $9.44K sold.

Quantbot Technologies first reported a position in KZR in Q1 2023 and held it in 3 quarters. The position peaked at $58.1K in Q2 2023. 81 funds tracked by Wall St. Rank hold KZR as of Q4 2023.

  • Quantbot Technologies reported no remaining Kezar Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Quantbot Technologies sold 793 Kezar Life Sciences shares in Q4 2023, an estimated $9.44K.
  • Quantbot Technologies first reported a position in Kezar Life Sciences in Q1 2023 and held it in 3 quarters.
  • Quantbot Technologies's Kezar Life Sciences position peaked at $58.1K in Q2 2023.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2023.

Based on Quantbot Technologies's 13F filing for Q4 2023, filed 14 Feb 2024.